FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1580924603> ?p ?o ?g. }

• W1580924603 abstract "An evidence-based clinical practice guideline on the optimal radiotherapeutic management of single and multiple brain metastases was developed. A systematic review and meta-analysis was performed. The Supportive Care Guidelines Group formulated clinical recommendations based on their interpretation of the evidence. External review of the report by Ontario practitioners was obtained through a mailed survey, and final approval was obtained from Cancer Care Ontario's Practice Guidelines Coordinating Committee (PGCC). One hundred and nine Ontario practitioners responded to the survey (return rate 44%). Ninety-six percent of respondents agreed with the interpretation of the evidence, and 92% agreed that the report should be approved. Minor revisions were made based on feedback from external reviewers and the PGCC. The PGCC approved the final practice guideline report. For adult patients with a clinical and radiographic diagnosis of brain metastases (single or multiple) we conclude that, • Surgical excision should be considered for patients with good performance status, minimal or no evidence of extracranial disease, and a surgically accessible single brain metastasis. • Postoperative whole brain radiotherapy (WBRT) should be considered to reduce the risk of tumour recurrence for patients who have undergone resection of a single brain metastasis. • Radiosurgery boost with WBRT may improve survival in select patients with unresectable single brain metastases. • The whole brain should be irradiated for multiple brain metastases. Standard dose-fractionation schedules are 3000 cGy in 10 fractions or 2000 cGy in 5 fractions. • Radiosensitizers are not recommended outside research studies. • In select patients, radiosurgery may be considered as boost therapy with WBRT to improve local tumour control. Radiosurgery boost may improve survival in select patients. • Chemotherapy as primary therapy or chemotherapy with WBRT remains experimental. • Supportive care is an option but there is a lack of Level 1 evidence as to which subsets of patients should be managed with supportive care alone. Qualifying statements addressing factors to consider when applying these recommendations are provided in the full report. The rigorous development, external review and approval process has resulted in a practice guideline that is strongly endorsed by Ontario practitioners." @default.
• W1580924603 created "2016-06-24" @default.
• W1580924603 creator A5031847465 @default.
• W1580924603 creator A5036667918 @default.
• W1580924603 creator A5082764228 @default.
• W1580924603 date "2005-04-04" @default.
• W1580924603 modified "2023-10-17" @default.
• W1580924603 title "Clinical practice guideline on the optimal radiotherapeutic management of brain metastases" @default.
• W1580924603 cites W1911884635 @default.
• W1580924603 cites W1956766950 @default.
• W1580924603 cites W1964905218 @default.
• W1580924603 cites W2000085543 @default.
• W1580924603 cites W2003917401 @default.
• W1580924603 cites W2004451956 @default.
• W1580924603 cites W2004630726 @default.
• W1580924603 cites W2018969856 @default.
• W1580924603 cites W2025578395 @default.
• W1580924603 cites W2037550193 @default.
• W1580924603 cites W2040059131 @default.
• W1580924603 cites W2041208884 @default.
• W1580924603 cites W2051841816 @default.
• W1580924603 cites W2061962226 @default.
• W1580924603 cites W2063000484 @default.
• W1580924603 cites W2064427333 @default.
• W1580924603 cites W2068214103 @default.
• W1580924603 cites W2069787488 @default.
• W1580924603 cites W2071990624 @default.
• W1580924603 cites W2091135228 @default.
• W1580924603 cites W2102113843 @default.
• W1580924603 cites W2113465576 @default.
• W1580924603 cites W2113517821 @default.
• W1580924603 cites W2131359324 @default.
• W1580924603 cites W2137510882 @default.
• W1580924603 cites W2154346936 @default.
• W1580924603 cites W2158789700 @default.
• W1580924603 cites W2170550919 @default.
• W1580924603 cites W2321905436 @default.
• W1580924603 cites W2327274121 @default.
• W1580924603 cites W2329793926 @default.
• W1580924603 cites W2409020857 @default.
• W1580924603 cites W2766048157 @default.
• W1580924603 cites W4239413529 @default.
• W1580924603 doi "https://doi.org/10.1186/1471-2407-5-34" @default.
• W1580924603 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1090562" @default.
• W1580924603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15807895" @default.
• W1580924603 hasPublicationYear "2005" @default.
• W1580924603 type Work @default.
• W1580924603 sameAs 1580924603 @default.
• W1580924603 citedByCount "39" @default.
• W1580924603 countsByYear W15809246032012 @default.
• W1580924603 countsByYear W15809246032013 @default.
• W1580924603 countsByYear W15809246032014 @default.
• W1580924603 countsByYear W15809246032015 @default.
• W1580924603 countsByYear W15809246032016 @default.
• W1580924603 countsByYear W15809246032017 @default.
• W1580924603 countsByYear W15809246032018 @default.
• W1580924603 countsByYear W15809246032019 @default.
• W1580924603 countsByYear W15809246032022 @default.
• W1580924603 crossrefType "journal-article" @default.
• W1580924603 hasAuthorship W1580924603A5031847465 @default.
• W1580924603 hasAuthorship W1580924603A5036667918 @default.
• W1580924603 hasAuthorship W1580924603A5082764228 @default.
• W1580924603 hasBestOaLocation W15809246031 @default.
• W1580924603 hasConcept C121608353 @default.
• W1580924603 hasConcept C126322002 @default.
• W1580924603 hasConcept C141071460 @default.
• W1580924603 hasConcept C142724271 @default.
• W1580924603 hasConcept C2778164965 @default.
• W1580924603 hasConcept C2779013556 @default.
• W1580924603 hasConcept C2780140570 @default.
• W1580924603 hasConcept C2780182762 @default.
• W1580924603 hasConcept C2780387249 @default.
• W1580924603 hasConcept C509974204 @default.
• W1580924603 hasConcept C71924100 @default.
• W1580924603 hasConceptScore W1580924603C121608353 @default.
• W1580924603 hasConceptScore W1580924603C126322002 @default.
• W1580924603 hasConceptScore W1580924603C141071460 @default.
• W1580924603 hasConceptScore W1580924603C142724271 @default.
• W1580924603 hasConceptScore W1580924603C2778164965 @default.
• W1580924603 hasConceptScore W1580924603C2779013556 @default.
• W1580924603 hasConceptScore W1580924603C2780140570 @default.
• W1580924603 hasConceptScore W1580924603C2780182762 @default.
• W1580924603 hasConceptScore W1580924603C2780387249 @default.
• W1580924603 hasConceptScore W1580924603C509974204 @default.
• W1580924603 hasConceptScore W1580924603C71924100 @default.
• W1580924603 hasIssue "1" @default.
• W1580924603 hasLocation W15809246031 @default.
• W1580924603 hasLocation W15809246032 @default.
• W1580924603 hasLocation W15809246033 @default.
• W1580924603 hasLocation W15809246034 @default.
• W1580924603 hasLocation W15809246035 @default.
• W1580924603 hasOpenAccess W1580924603 @default.
• W1580924603 hasPrimaryLocation W15809246031 @default.
• W1580924603 hasRelatedWork W1534049499 @default.
• W1580924603 hasRelatedWork W1674659500 @default.
• W1580924603 hasRelatedWork W1964497241 @default.
• W1580924603 hasRelatedWork W2053970939 @default.
• W1580924603 hasRelatedWork W2411065754 @default.
• W1580924603 hasRelatedWork W2443709416 @default.
• W1580924603 hasRelatedWork W3094184311 @default.

• next